logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Colonic Neoplasms

    FiltersReset Filters
    8 results

    • capecitabine

      (capecitabine)
      BluePoint Laboratories
      Usage: Capecitabine is indicated for the treatment of various cancers, including Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, and unresectable or metastatic gastric and pancreatic cancers, often in combination with other chemotherapy agents.

    • capecitabine

      (Capecitabine)
      Aurobindo Pharma Limited
      Usage: Capecitabine tablets are indicated for the treatment of Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, unresectable gastric or esophageal cancers, and as adjuvant therapy for pancreatic adenocarcinoma in combination with chemotherapy regimens.

    • fluorouracil

      (FLUOROURACIL)
      Eugia US LLC
      Usage: Fluorouracil injection is indicated for treating patients with adenocarcinoma of the colon and rectum, breast, stomach, and pancreas.

    • irinotecan hydrochloride

      (Irinotecan Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Irinotecan Hydrochloride Injection is indicated for patients with metastatic colon or rectal carcinoma that has recurred or progressed after initial treatment with fluorouracil-based therapy.

    • oxaliplatin

      (Oxaliplatin)
      Sandoz Inc
      Usage: Oxaliplatin injection, combined with infusional fluorouracil and leucovorin, is indicated for the adjuvant treatment of stage III colon cancer post-complete tumor resection and for the treatment of advanced colorectal cancer.

    • oxaliplatin

      (Oxaliplatin)
      NorthStar RxLLC
      Usage: Oxaliplatin Injection, combined with infusional fluorouracil and leucovorin, is indicated for the adjuvant treatment of stage III colon cancer post-surgery and for the treatment of advanced colorectal cancer.

    • oxaliplatin

      (Oxaliplatin)
      Baxter Healthcare Corporation
      Usage: Oxaliplatin injection, in combination with infusional fluorouracil and leucovorin, is indicated for the adjuvant treatment of stage III colon cancer post-surgery and for the treatment of advanced colorectal cancer.

    • oxaliplatin

      (Oxaliplatin)
      Meitheal Pharmaceuticals Inc.
      Usage: Oxaliplatin Injection, combined with infusional fluorouracil and leucovorin, is indicated for the adjuvant treatment of stage III colon cancer post-tumor resection and for the treatment of advanced colorectal cancer.